Posted on 06/16/2021 7:11:59 PM PDT by thecodont
Didn’t see the word “vaccine” anywhere in the article and I read it twice.
Wonder if they’re trying to prepare the public for something?
CYA for vax manufacturers, even if the “new conditions” have nothing to do with either the vax or the virus.
This IS the New York Times - the paper of record - where any article published must conform to rigid ideological guidelines ...
Don’t most of the patients with severe CoupFlu have preexisting conditions?
Maybe it’s not the CoupFlu.
Anecdotal to be sure, my friend was in the hospital over Christmas with Covid. She now has lung polyps and a hyper dense kidney. Neither of which she had pre covid.
I-RECOVER Protocol for Long Haul COVID Syndrome
https://covid19criticalcare.com/covid-19-protocols/i-recover-protocol/
From link (go to link to see protocol chart):
The Long Haul COVID Syndrome (LHCS) is an often debilitating syndrome characterized by a multitude of symptoms such as prolonged malaise, headaches, generalized fatigue, sleep difficulties, smell disorder, decreased appetite, painful joints, dyspnea, chest pain and cognitive dysfunction. The incidence of symptoms after COVID varies from as low as 10% to as high as 80%. LHCS is not only seen after the COVID infection but it is being observed in some people that have received vaccines (likely due to monocyte activation by the spike protein from the vaccine). A puzzling feature of the LHCS syndrome is that it is not predicted by initial disease severity; post-COVID-19 frequently affects mild-to-moderate cases and younger adults that did not require respiratory support or intensive care.
The symptom set of LHCS in the majority of cases is very similar to the chronic inflammatory response syndrome (CIRS)/ myalgic encephalomyelitis/chronic fatigue syndrome, although in LHCS, symptoms tend to improve slowly in the majority of the cases. Furthermore, the similarity between the mast cell activation syndrome and LHCS has been observed, and many consider post-COVID to be a variant of the mast cell activation syndrome. The LHCS syndrome is highly heterogenous and likely results from a variety of pathogenetic mechanisms. Furthermore, it is likely that delayed treatment (with ivermectin) in the early symptomatic phase will result in a high viral load, which increases the risk and severity of LHCS.
Although numerous reports describe the epidemiology and clinical features of LHCS, studies evaluating treatment options are glaringly sparse. Indeed, the NICE guideline for managing the long-term effects of COVID-19 provide no specific pharmacologic treatment recommendations.
Given the lack of available treatment recommendations in the setting of large numbers of patients suffering with this disorder globally, the FLCCC developed the I-RECOVER protocol in collaboration with a number of expert clinicians including Dr. Mobeen Syed, Dr. Ram Yogendra, Dr. Bruce Patterson, and Dr. Tina Peers. Although our varied yet often overlapping treatment approaches were initially empiric, while based on both preliminary investigations into and prevailing theoretical pathophysiologic mechanisms of LHCS, the consistently positive clinical responses observed, often profound and sustained, led the collaboration to form the consensus protocol below. As with all FLCCC protocols, we must emphasize that multiple aspects of the protocol may change as scientific data and clinical experience in this condition evolve, thus it is important to check back frequently or join the FLCCC Alliance to receive notification of any protocol changes.
It’s a Chicom bioweapon. Long COVID is a feature, not a bug.
https://nypost.com/2021/06/06/damning-science-shows-covid-19-likely-engineered-in-lab/
16 June: Business Insider: China’s COVID-19 vaccines are being called into question after infections surged in countries using Chinese shots
by Marianne Guenot
https://www.msn.com/en-au/news/world/china-s-covid-19-vaccines-are-being-called-into-question-after-infections-surged-in-countries-using-chinese-shots/ar-AAL6Pjb?ocid=msedgntp
The disease can have consequences. Wife & I had a mild case; recovery wasn’t 100%.
Well, if TPTB had not outlawed prophylactic early intervention to prevent people from getting so sick, there just might not be all these problems.
“Don’t most of the patients with severe CoupFlu have preexisting conditions?
Maybe it’s not the CoupFlu.”
***************************************************
I wouldn’t rule that out as possibly have some effect. This is the first time I saw the results of an actual study of post-COVID infection health. Seen lots of anecdotal reports. I’m sure there will be further studies.
I had a cold in 1985. It lingered. Turned into bronchitis. In 2016, I found I had lung damage and scar tissue from that.
The illnesses we have can often have long-lasting effects.
Shhhh! You’re spoiling the narrative.
See 13 for an anecdotal report.
I’m curious what percent of these individuals also received the vaccine? I’m not saying there’s a connection, because of course I don’t know, but I do find it odd that they gave lots of information, but not that piece. Are they not tracking that or just not reporting it? We should be looking at absolutely every possible variable so that we can be figuring out what is going on and how we can minimize these conditions.
I have heard many claims in the media that people with long term symptoms almost immediately get better after being injected.
Although I am skeptical, I can see a mechanism that might make it possible.
I have not looked for any studies on this
Exactly. It's a huge, glaring hole in the story.
Yep. Me and my kids had it. Still no smell , little taste and some other issues over a month out with a mild case- or at least seemed mild / early ivermectin and major symptoms knocked out quickly.. Total bioweapon. Weird.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.